Diosmectite
Smecta and Smecta orange-vanille are different trade names for the same drug.
This medication should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist.
Due to its structure and high viscosity, Smecta has strong coating properties, reinforcing the barrier that protects the gastrointestinal mucosa from irritating factors and pathogens.
Smecta is used:
If there is no improvement or the patient feels worse after 2-3 days, they should contact their doctor.
Long-term or frequent use of Smecta is not recommended without consulting a doctor.
Before starting Smecta, consult a doctor or pharmacist:
During diarrhea treatment, it is necessary to replenish fluids and electrolytes. The volume of administered solutions and their route of administration should be adjusted according to the patient's age, health status, and severity of diarrhea.
Consult a doctor:
Smecta should not be used in infants and children under 2 years of age. In children over 2 years of age, acute diarrhea must be treated in combination with early administration of oral rehydration fluid to avoid dehydration. Long-term use of Smecta is not recommended.
Tell your doctor or pharmacist about all medications the patient is currently taking or has recently taken, as well as any medications they plan to take.
The adsorptive properties of this medication may affect the rate and/or extent of absorption of other substances. Therefore, no other medication should be administered at the same time as diosmectite.
A 2-hour interval is recommended between taking Smecta and other medications.
There are no data or limited data on the use of Smecta in pregnant or breastfeeding women.
Smecta should not be used during pregnancy.
Smecta should not be used during breastfeeding.
The effect of Smecta on fertility in humans has not been evaluated.
No studies have been conducted on the effect of Smecta on the ability to drive and use machines, but it is expected that there will be no such effect.
If the patient has previously been diagnosed with an intolerance to some sugars, they should consult their doctor before taking Smecta.
Smecta contains 0.679 g of glucose in one sachet. This should be taken into account in patients with diabetes.
This medication should always be used exactly as described in the patient leaflet or as directed by a doctor or pharmacist. If in doubt, consult a doctor or pharmacist.
Usually, 3 sachets per day are used. At the beginning of an acute diarrhea episode, the dose can be doubled (i.e., up to 6 sachets per day)
Usually, 3 sachets per day are used
If there is no improvement or the patient feels worse after 2-3 days, they should contact their doctor. Long-term or frequent use of Smecta is not recommended without consulting a doctor.
Oral administration.
Before administration, the contents of the sachet should be dissolved in a liquid until a suspension is obtained.
In children over 2 years of age: the contents of the sachet can be dissolved in a 50 ml bottle of water and administered in small portions throughout the day; it can also be mixed with semi-liquid foods: broth, cooked fruits, purees, or baby food.
In adults: the contents of the sachet can be dissolved in half a glass of water.
Taking more than the recommended dose of Smecta may cause severe constipation or the formation of a bezoar, which is an accumulation of undigested substances in the gastrointestinal tract.
If more than the recommended dose of Smecta is taken, consult a doctor.
Do not take a double dose to make up for a missed dose.
If you have any further doubts about the use of this medication, consult a doctor or pharmacist.
Like all medications, Smecta can cause side effects, although not everybody gets them.
Other side effects include:
Common (may affect up to 1 in 10 people):
Uncommon (may affect up to 1 in 100 people):
Rare (may affect up to 1 in 1,000 people)
If you experience any side effects, including any side effects not listed in this leaflet, inform your doctor or pharmacist. Side effects can be reported directly to the Department of Post-Marketing Surveillance of Adverse Reactions to Medicinal Products, Medical Devices, and Biocidal Products, Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl.
Reporting side effects will help gather more information on the safety of this medication.
Keep the medication out of sight and reach of children.
Store in a dry place.
Do not use this medication after the expiration date stated on the packaging. The expiration date refers to the last day of the specified month.
Medications should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of unused medications. This will help protect the environment.
Smecta is a powder for oral suspension in sachets.
Smecta is available in packages containing 10 or 30 sachets in a cardboard box.
For more detailed information, consult the marketing authorization holder or parallel importer.
IPSEN Consumer HealthCare
65, quai Georges Gorse
92100 Boulogne-Billancourt
France
BEAUFOUR IPSEN INDUSTRIE
Usine des Fontaines
20, rue Ethe Virton
28100 Dreux
France
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Authorization number in France, the country of export:34009 319 230 7 7
34009 319 231 3 8
319 230-7
319 231-3
Parallel import authorization number:34/08
Date of leaflet approval: 17.03.2023
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.